At a Senate hearing several weeks ago, Janet Woodcock, director of the Food and Drug Administration’s Center for Drug Evaluation and Research, assured the American public that the heparin found in the
Woodcock’s reassurance, however, was met with a warning to the Senate Health, Education, Labor, and Pensions Committee that the FDA is underfunded, a 20h-century domestic agency battling to protect American consumers in a globalized, 21st-century world. She asks that the FDA be given more inspectors, modern information technology systems and enhanced science. Dr. Woodcock, however, would not give the Senate a specific price of how much money the FDA needed for the task. By the end of the year, the FDA is set to open three offices in
Comments for this article are closed.